The effectiveness of vaccination against measles, the leading cause of vaccine-preventable
deaths in infants globally, is greatly impacted by the level of maternal antibody to measles …

This paper reviews literature on passively transferred maternal antibodies against measles
in infants. The amount and decay of these antibodies can be a result of changing patterns in …

Objective To investigate the duration of the presence of maternal antibodies to measles in
infants. Design Prospective study (May 2006 to November 2008). Setting Five hospitals in …

Vaccines that successfully prevent severe infant respiratory virus diseases should induce
protection at a very young age because of the low age of patients who are hospitalized …

Introduction Young infants are protected from measles infection by maternal measles
antibodies. The level of these antibodies at birth depends on the level of antibodies in the …

Background. In developing countries vaccination against measles virus (MV) is generally
administered at 9 months of age, although it is well-documented that protection of most …

Abstract Background. The Republic of the Marshall Islands (RMI) is a South Pacific nation
freely associated with the United States. In 2003, the RMI experienced the largest measles …

Background The reported coverage rates of first and second doses of measles containing
vaccine (MCV) are almost 95% in China, while measles cases are constantly being …

Children aged 9–11, 12–14 or 15–17 months, respectively were vaccinated with a measles,
mumps and rubella (MMR) vaccine and serum antibody responses and reactogenicity were …

Over the last seven years, and especially in 2001, a declining coverage for MMR vaccination
in 2-year-olds has been noted in Sweden. By recording actual date of vaccination in a cohort …